[HTML][HTML] Cellular and molecular regulation of muscle regeneration

SBP Chargé, MA Rudnicki - Physiological reviews, 2004 - journals.physiology.org
Chargé, Sophie BP, and Michael A. Rudnicki. Cellular and Molecular Regulation of Muscle
Regeneration. Physiol Rev 84: 209–238, 2004; 10.1152/physrev. 00019.2003.—Under …

[HTML][HTML] Stem and progenitor cells in skeletal muscle development, maintenance, and therapy

B Péault, M Rudnicki, Y Torrente, G Cossu… - Molecular therapy, 2007 - cell.com
Satellite cells are dormant progenitors located at the periphery of skeletal myofibers that can
be triggered to proliferate for both self-renewal and differentiation into myogenic cells. In …

[HTML][HTML] PAI-1, the plasminogen system, and skeletal muscle

FA Rahman, MP Krause - International journal of molecular sciences, 2020 - mdpi.com
The plasminogen system is a critical proteolytic system responsible for the remodeling of the
extracellular matrix (ECM). The master regulator of the plasminogen system, plasminogen …

Muscle-derived stem cells for musculoskeletal tissue regeneration and repair

H Peng, J Huard - Transplant immunology, 2004 - Elsevier
Muscle recently has been identified as a good source of adult stem cells that can
differentiate into cells of different lineages. The most well-known muscle progenitor cells are …

[HTML][HTML] Macrophages improve survival, proliferation and migration of engrafted myogenic precursor cells into MDX skeletal muscle

PF Lesault, M Theret, M Magnan, S Cuvellier, Y Niu… - 2012 - journals.plos.org
Transplantation of muscle precursor cells is of therapeutic interest for focal skeletal muscular
diseases. However, major limitations of cell transplantation are the poor survival, expansion …

Acute vascular rejection of xenografts: roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant …

B Gollackner, SK Goh, I Qawi, L Buhler… - …, 2004 - journals.lww.com
Background. Hyperacute rejection of vascularized discordant xenografts can now be
effectively managed. However, acute vascular rejection (AVR) then ensues, resulting in graft …

Myoblast transplantation: the current status of a potential therapeutic tool for myopathies

D Skuk, JP Tremblay - Journal of Muscle Research & Cell Motility, 2003 - Springer
The implantation of cultured myogenic cells into the body (myoblast transplantation) is an
experimental strategy that is being explored for the potential treatment of myopathies. Its …

Progress in therapy for Duchenne muscular dystrophy

RJ Fairclough, A Bareja, KE Davies - Experimental physiology, 2011 - Wiley Online Library
Duchenne muscular dystrophy is a devastating muscular dystrophy of childhood. Mutations
in the dystrophin gene destroy the link between the internal muscle filaments and the …

Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo

JF Lafreniere, P Mills, M Bouchentouf… - Experimental cell …, 2006 - Elsevier
Different molecules are available to recruit new neighboring myogenic cells to the site of
regeneration. Formerly called B cell stimulatory factor-1, IL-4 can now be included in the list …

uPA deficiency exacerbates muscular dystrophy in MDX mice

M Suelves, B Vidal, AL Serrano, M Tjwa… - The Journal of cell …, 2007 - rupress.org
Duchenne muscular dystrophy (DMD) is a fatal and incurable muscle degenerative disorder.
We identify a function of the protease urokinase plasminogen activator (uPA) in mdx mice, a …